United States v. Skrmetti
Headline: Court upholds Tennessee law blocking puberty blockers and cross‑sex hormones for transgender minors, allowing states to limit gender‑affirming medical care for children while permitting those drugs for other medical uses.
Holding: The Court rules that Tennessee’s ban on certain puberty blockers and hormones for minors does not trigger heightened equal‑protection review and is constitutional under rational‑basis review, so the law is upheld.
- Lets states ban hormones and puberty blockers for transgender minors.
- Leaves medical and policy debates to state lawmakers and regulators.
- Creates legal precedent reducing federal constitutional protection for these treatments.
Summary
Background
In 2023 Tennessee passed SB1, a law that stops doctors from prescribing, giving, or performing puberty blockers or cross‑sex hormones to any minor when the purpose is to help the child "identify with, or live as" an identity inconsistent with the minor’s biological sex or to treat distress from that discordance. The law allows the same drugs for adults and for minors when used to treat a congenital defect, precocious puberty, disease, or injury. Three transgender minors, their parents, and a doctor sued, and a federal judge partly blocked the law. The Sixth Circuit reversed that injunction, and the Supreme Court agreed to decide the equal‑protection claim.
Reasoning
The Court asked whether SB1 violates the Fourteenth Amendment’s guarantee of equal treatment. The majority held SB1 is not subject to heightened scrutiny because on its face it classifies by age and by the medical purpose for treatment, not directly by sex or transgender status. The Court relied on precedents saying laws that single out medical uses or conditions are reviewed under a lenient standard. The Court then applied rational‑basis review and found Tennessee’s findings about medical uncertainty, risks, and minors’ vulnerability gave a conceivable reason for the law. The result: the Court affirmed the Sixth Circuit and upheld the law.
Real world impact
The decision lets Tennessee enforce a broad ban on gender‑affirming hormones and puberty blockers for minors and gives states flexibility to enact similar limits. It will affect transgender adolescents seeking these treatments, their families, and doctors. The Court emphasized these policy disputes belong mainly to voters, doctors, and legislatures.
Dissents or concurrances
Justice Sotomayor (joined by Justice Jackson) dissented, arguing the law classifies on the basis of sex and should have received heightened review; other Justices filed separate concurring opinions emphasizing deference to legislatures and medical uncertainty.
Ask about this case
Ask questions about the entire case, including all opinions (majority, concurrences, dissents).
What was the Court's main decision and reasoning?
How did the dissenting opinions differ from the majority?
What are the practical implications of this ruling?